• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV701T
Device Problem Mechanical Problem (1384)
Patient Problem Hydrocephalus (3272)
Event Date 12/15/2023
Event Type  Injury  
Manufacturer Narrative
Investigation: visual inspection.During the investigation, a deformation of the outer housing of the prosa could be determined.The measurement of the plane parallelism could confirm that with a value of -0.088 mm - outside tolerance (0 0.02 mm).Permeability test.A permeability test has shown that the valve is permeable.Computer controlled test.To investigate the flow rate, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in both the horizontal as well as the vertical positions.The results show that the prosa operates within the accepted tolerance in either position.Adjustment test.The prosa valve was tested and is adjustable to all specified pressures.Braking force and brake function test.The brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Internal inspection.After dismantling of the valve, deposits were found in the prosa.Results.Based on our investigation results, we can determine deposits and a deformation.The deposits and the deformation had no affect to the technical properties at the time of the investigation.The cause of the aforementioned functional impairment is not known to us at the time of the examination.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event Description
It was reported that a prosa (#fv701t) was implanted during a procedure performed on (b)(6) 2016.According to the complainant, the valve was believed to be operated in adjustment difficulties.The patient underwent a revision procedure.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 48 years.Height: 186 cm.Weight: 128 kg.Gender: unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key18498159
MDR Text Key332725666
Report Number3004721439-2024-00003
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906133023
UDI-Public4041906133023
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/29/2020
Device Model NumberFV701T
Device Catalogue NumberFV701T
Device Lot Number20017083
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/02/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age48 YR
Patient Weight128 KG
-
-